Commit To Buy Cellular Biomedicine Group At $12.50, Earn 21.4% Annualized Using Options
July 28, 2016 at 11:51 AM EDT
Investors eyeing a purchase of Cellular Biomedicine Group Inc (CBMG) shares, but cautious about paying the going market price of $14.88/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2017 put at the $12.50 strike, which has a bid at the time of this writing of $1.70..